Age-Related Macular Degeneration: 68-Market Analysis and Sales Forecast tp 2034
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Age-Related Macular Degeneration (AMD) market.
Across the 68 markets, sales in the AMD market were $8.9 billion in 2024, growing to $24.1 billion in 2034.
The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 87.0% and 85.2% in 68-market sales in 2024 and 2034, respectively.
Scope
This publication is an expanded version of the Excel model containing the patient-based forecast sales for AMD, covered in GlobalData’s report “Age-Related Macular Degeneration: Seven-Market Analysis and Sales Forecast”, published in December 2025. In addition to patient based forecast sales data for the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan), this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
Reasons to Buy
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the 68M AMD therapeutics market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 68M AMD therapeutics market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
AbbVie
Adverum Biotechnologies
AiViVa BioPharma
Alkeus Pharmaceuticals
Allegro Opthalmics
Annexon
Apellis
Ashvattha Therapeutics
Astellas
Aviceda Therapeutics
Bausch & Lomb
Bayer
Belite Bio
Boehringer Ingelheim
CHEPLAPHARM
Chugai
Clearside Biomedical
EyePoint Pharmaceuticals
Genentech
Guangzhou Yinming Biomedical Technology Co Ltd
Kodiak Sciences
Luxa Biotechnology
Merck
Novartis
Ocugen
Ocular Therapeutix
Outlook Therapeutics
QLT Inc
Regeneron
REGENEXBIO
Roche
Santen
Stealth BioTherapeutics
Sylentis
Table of Contents
Table
Figures
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Age Related Macular Degeneration reports